Tracey L McCain's Net Worth
$7.89 Million
Who is Tracey L McCain?
Tracey L McCain has an estimated net worth of $7.89 Million. This is based on reported shares across multiple companies, which include ImmunoGen, Inc., Kiniksa Pharmaceuticals, Ltd., and Blueprint Medicines Corp.
SEC CIK
Tracey L McCain's CIK is 0001683600
Past Insider Trading and Trends
2022 was Tracey L McCain's most active year for acquiring shares with 12 total transactions. Tracey L McCain's most active month to acquire stocks was the month of May. 2021 was Tracey L McCain's most active year for disposing of shares, totalling 13 transactions. Tracey L McCain's most active month to dispose stocks was the month of February. 2021 saw Tracey L McCain paying a total of $992,600.00 for 107,424 shares, this is the most they've acquired in one year. In 2021 Tracey L McCain cashed out on 71,893 shares for a total of $3,924,892.77, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ImmunoGen, Inc. (IMGN) Snapshot price: $29.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Kiniksa Pharmaceuticals, Ltd. (KNSA) Snapshot price: $18.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Blueprint Medicines Corp (BPMC) Snapshot price: $74.47
EVP AND CHIEF LEGAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -7.91% | -5.19K |
$90.69 | -$471,043.86 | 60.5K |
Mar 7
| |||
Form 4
| +23.50% | 12.5K |
—
|
—
| 65.69K |
Mar 1
| |||
Form 4
| -5.93% | -3.32K |
$45.68 | -$151,742.98 | 52.67K |
Mar 6
| |||
Form 4
| +28.74% | 12.5K |
—
|
—
| 55.99K |
Mar 1
| |||
Form 4
| -5.91% | -2.71K |
$58.70 | -$159,317.69 | 43.23K |
Mar 3 - Mar 7
| |||
Form 4
| +37.38% | 12.5K |
—
|
—
| 45.94K |
Mar 1
| |||
Form 4
|
—
|
0
|
$62.83 | -$344,690.24 | 33.44K |
Scheduled
|
Dec 7
| ||
Form 4
|
—
|
0
|
$69.46 | -$411,012.00 | 33.27K |
Scheduled
|
Nov 3
| ||
Form 4
|
—
|
0
|
$68.60 | -$2,012,348.61 | 33.27K |
Scheduled
|
Sep 23
| ||
Form 4
| -5.45% | -1.89K |
$86.76 | -$164,241.92 | 32.85K |
Mar 4
| |||
Form 4
| +60.24% | 13.06K |
—
|
—
| 34.74K |
Mar 1
| |||
Form 4
| -2.77% | -617.00 |
$51.98 | -$32,071.66 | 21.68K |
Mar 9
| |||
Form 4
| +177.02% | 14.25K |
—
|
—
| 22.3K |
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
$58.35 | -$599,849.74 |
0
|
Scheduled
|
Feb 27
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||